The new top 20 phar­ma list: Take­da jumps on, Bio­gen pushed out — and more big changes are on the way

Christophe We­ber Take­da

Take­da CEO Christophe We­ber is get­ting the Big Phar­ma sta­tus he want­ed with his $62 bil­lion Shire buy­out. The phar­ma com­pa­ny, with a big R&D hub in Boston/Cam­bridge, has leapt on to the top 20 list of the world’s largest phar­ma caps, as ranked by Glob­al­Da­ta us­ing end-of-Q1 mar­ket caps.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER